Understanding different types of sepsis in Kilimanjaro, Tanzania
Sepsis Characterization in Kilimanjaro
['FUNDING_R01'] · DUKE UNIVERSITY · NIH-10908347
This study is looking at sepsis, a serious infection that can be life-threatening, especially in places like Tanzania, to find out the different types of sepsis that people experience there, so doctors can provide better treatments and care for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10908347 on ClinicalTrials.gov |
What this research studies
This research investigates sepsis, a severe infection that can lead to death, particularly in low-income countries like Tanzania. By using advanced statistical methods, the study aims to identify specific subtypes of sepsis that are prevalent in the region, which can help in tailoring treatments and improving patient outcomes. The research will analyze existing data from previous studies and conduct new observations in local hospitals to better understand how sepsis manifests in this population. Ultimately, the goal is to enhance detection and management strategies for sepsis in resource-limited settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults experiencing severe sepsis or related conditions in Kilimanjaro, Tanzania.
Not a fit: Patients outside of the Kilimanjaro region or those not experiencing sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for sepsis, potentially saving lives in affected populations.
How similar studies have performed: Previous research has shown promise in using data-driven approaches to characterize diseases, suggesting that this method could be effective for sepsis as well.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RUBACH, MATTHEW P — DUKE UNIVERSITY
- Study coordinator: RUBACH, MATTHEW P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.